Continuous Glucose Monitoring (CGM) After Kidney Transplantation
Continuous Glucose Monitoring in Kidney Transplant Recipients with Diabetes, Pre-diabetes and Without Diabetes
Bo Feldt-Rasmussen
54 participants
Nov 12, 2024
OBSERVATIONAL
Conditions
Summary
This study examines glucose levels measured by continuous glucose monitoring (CGM) in the immediate period following kidney transplantation among recipients with diabetes, without diabetes, and with pre-diabetes. The primary objective is to analyse differences in mean sensor glucose between these three groups. CGMs are applied to participants within 72 hours after kidney transplantation, with a total of 54 participants divided equally across the three groups (18 in each). Secondary objectives include assessing additional glucose profile indices, adherence to relevant guidelines, changes in HbA1c, the impact of immunosuppression and steroid dosage, and beta cell function.
Eligibility
Inclusion Criteria3
- Written informed consent obtained before CGM application
- Male or female; age: ≥18 years
- Kidney transplantation
Exclusion Criteria4
- Unable to cooperate to CGM the first ten days after surgery
- Allergic to plasters in CGM units
- Combined kidney and liver or pancreatic transplantation
- Graft loss/rejection within first 48 hours after transplantation
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06675903